Search

Search Results
Results 8321 - 8330 of 8408 for allergy
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Glyade MR
    Drug - 1 Aug 2022
    Consumer Medicine Information (CMI) about Glyade MR (containing gliclazide) intended for persons living in Australia.
  • Temizole
    Drug - 1 Aug 2022
    Consumer Medicine Information (CMI) about Temizole intended for persons living in Australia.
  • Inqovi
    Drug - 27 Jul 2022
    Consumer Medicine Information (CMI) about Inqovi intended for persons living in Australia.
  • Duride
    Drug - 25 Jul 2022
    Consumer Medicine Information (CMI) about Duride intended for persons living in Australia.
  • Diamicron 60mg MR
    Drug - 18 Jul 2022
    Consumer Medicine Information (CMI) about Diamicron 60mg MR (containing gliclazide) intended for persons living in Australia.
  • Ardix Gliclazide 60mg MR
    Drug - 18 Jul 2022
    Consumer Medicine Information (CMI) about Ardix Gliclazide 60mg MR (containing gliclazide) intended for persons living in Australia.
  • Neo-B12 Injection
    Drug - 13 Jul 2022
    Consumer Medicine Information (CMI) about Neo-B12 Injection intended for persons living in Australia.
  • Bupivadren
    Drug - 4 Jul 2022
    Consumer Medicine Information (CMI) about Bupivadren intended for persons living in Australia.
  • Busulfex
    Drug - 28 Jun 2022
    Consumer Medicine Information (CMI) about Busulfex intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback